Healthcare Services Group, Inc. (HCSG)
NASDAQ: HCSG · Real-Time Price · USD
18.97
-0.19 (-0.99%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Healthcare Services Group Stock Forecast
Stock Price Forecast
The 6 analysts that cover Healthcare Services Group stock have a consensus rating of "Buy" and an average price target of $19.83, which forecasts a 4.53% increase in the stock price over the next year. The lowest target is $15 and the highest is $24.
Price Target: $19.83 (+4.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthcare Services Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Initiates $22 | Hold | Initiates | $22 | +15.97% | Mar 3, 2026 |
| BMO Capital | BMO Capital | Hold Initiates $20 | Hold | Initiates | $20 | +5.43% | Nov 13, 2025 |
| UBS | UBS | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +15.97% | Oct 28, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $19 → $24 | Strong Buy | Maintains | $19 → $24 | +26.52% | Oct 23, 2025 |
| Macquarie | Macquarie | Hold → Buy Upgrades $15 → $16 | Hold → Buy | Upgrades | $15 → $16 | -15.66% | Jul 29, 2025 |
Financial Forecast
Revenue This Year
1.97B
from 1.84B
Increased by 7.39%
Revenue Next Year
2.08B
from 1.97B
Increased by 5.22%
EPS This Year
0.97
from 0.81
Increased by 19.31%
EPS Next Year
1.10
from 0.97
Increased by 14.25%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.0B | 2.2B | |
| Avg | 2.0B | 2.1B | |
| Low | 1.9B | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.8% | 9.2% | |
| Avg | 7.4% | 5.2% | |
| Low | 2.9% | 0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.04 | 1.27 | |
| Avg | 0.97 | 1.10 | |
| Low | 0.88 | 0.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.3% | 31.5% | |
| Avg | 19.3% | 14.2% | |
| Low | 8.9% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.